[PDF][PDF] Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles

A Becerra-Artiles, JM Calvo-Calle, PP Nanaware… - Cell Reports, 2022 - cell.com
A Becerra-Artiles, JM Calvo-Calle, PP Nanaware, J Cruz, GC Weaver, L Lu, C Forconi
Cell Reports, 2022cell.com
Sequence homology between SARS-CoV-2 and common-cold human coronaviruses
(HCoVs) raises the possibility that memory responses to prior HCoV infection can affect T
cell response in COVID-19. We studied T cell responses to SARS-CoV-2 and HCoVs in
convalescent COVID-19 donors and identified a highly conserved SARS-CoV-2 sequence,
S 811-831, with overlapping epitopes presented by common MHC class II proteins HLA-
DQ5 and HLA-DP4. These epitopes are recognized by low-abundance CD4 T cells from …
Summary
Sequence homology between SARS-CoV-2 and common-cold human coronaviruses (HCoVs) raises the possibility that memory responses to prior HCoV infection can affect T cell response in COVID-19. We studied T cell responses to SARS-CoV-2 and HCoVs in convalescent COVID-19 donors and identified a highly conserved SARS-CoV-2 sequence, S811-831, with overlapping epitopes presented by common MHC class II proteins HLA-DQ5 and HLA-DP4. These epitopes are recognized by low-abundance CD4 T cells from convalescent COVID-19 donors, mRNA vaccine recipients, and uninfected donors. TCR sequencing revealed a diverse repertoire with public TCRs. T cell cross-reactivity is driven by the high conservation across human and animal coronaviruses of T cell contact residues in both HLA-DQ5 and HLA-DP4 binding frames, with distinct patterns of HCoV cross-reactivity explained by MHC class II binding preferences and substitutions at secondary TCR contact sites. These data highlight S811-831 as a highly conserved CD4 T cell epitope broadly recognized across human populations.
cell.com